EntryPoint Capital’s Accendra Health ACH Stock Holding History

EntryPoint Capital’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-36,958	Closed	-$177K	–	810
2025 Q3	$177K	Buy	+36,958	New	+$235K	0.07%	572
2025 Q2	–	Sell	-13,954	Closed	-$126K	–	761
2025 Q1	$126K	Buy	+13,954	New	+$147K	0.06%	606
2024 Q1	–	Sell	-3,026	Closed	-$58.3K	–	1659
2023 Q4	$58.3K	Buy	+3,026	New	+$54.8K	0.06%	640

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

EntryPoint Capital's ACH Position: Q4 2025 in Review

EntryPoint Capital sold out of Accendra Health (ACH) in Q4 2025, closing a stake of 36,958 shares — an estimated $177K sold.

EntryPoint Capital first reported a position in ACH in Q4 2023 and held it in 3 quarters. The position peaked at $177K in Q3 2025. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.

EntryPoint Capital reported no remaining Accendra Health position as of Q4 2025 after selling out during the quarter.
EntryPoint Capital sold 36,958 Accendra Health shares in Q4 2025, an estimated $177K.
EntryPoint Capital first reported a position in Accendra Health in Q4 2023 and held it in 3 quarters.
EntryPoint Capital's Accendra Health position peaked at $177K in Q3 2025.
168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.

Based on EntryPoint Capital's 13F filing for Q4 2025, filed 12 Feb 2026.